Skip to content

Efficacy of medium length catheters and CVC catheters in intravenous infusion therapy in patients with sepsis: a randomized, single-blind, controlled study

Efficacy of medium length catheters and CVC catheters in intravenous infusion therapy in patients with sepsis: a randomized, single-blind, controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090973
Enrollment
Unknown
Registered
2024-10-16
Start date
2024-10-18
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Midline Catheter:The experimental group was implanted with a medium length catheter
CVC Catheter:The experimental group was implanted with a CVC catheter

Sponsors

The Second Affiliated Hospital of Guizhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age =18 years old, gender unlimited; (2) Septic patients requiring catheterization; (3) Patients with good treatment compliance; (4) The skin of the puncture site is intact, without rupture or damage, and the vascular elasticity is good, which is suitable for puncture; (5) Patients whose laboratory test results show that platelet and coagulation function are in the normal range; (6) Obtain informed consent from patients or family members.

Exclusion criteria

Exclusion criteria: (1) septic shock patients; (2) Venous thrombosis at the puncture site; (3) ipsilateral arteriovenous fistula; (4) Pain, infection, vascular damage (phlebitis, sclerosis, etc.), planned surgery or radiotherapy in the intended piercing limb; (5) superior vena cava compression syndrome; (6) Limb deformity, joint dysfunction; (7) There were obvious malunion of thoracic malformations and clavicle fractures; (8) A history of hypercoagulability, reduced venous blood flow in the extremities (e.g. paralysis, orthosis); (9) Patients with axillary lymph nodes and lymphedema undergoing breast surgery; (10) Patients with established or suspected catheter-associated infection; (11) Patients with allergies, who have been identified or suspected to be allergic to infusion catheter materials.

Design outcomes

Primary

MeasureTime frame
The success rate of puncture in two groups was observed. ? Record the operation time of the two groups;The success rate of puncture in two groups was observed. ? Record the operation time of the two groups;

Secondary

MeasureTime frame
The occurrence of complications after 7 days of catheterization was recorded in the two groups. (2) Record the expenses of the two groups; ? The post-catheterization care of the two groups was recorded; (4) Subjective comfort scores of the two groups after catheterization;? The occurrence of complications after 7 days of catheterization was recorded in the two groups. (2) Record the expenses of the two groups; ? The post-catheterization care of the two groups was recorded; (4) Subjective comfort scores of the two groups after catheterization;? The occurrence of complications after 7 days of catheterization was recorded in the two groups. (2) Record the expenses of the two groups; ? The post-catheterization care of the two groups was recorded; (4) Subjective comfort scores of the two groups after catheterization;? The occurrence of complications after 7 days of catheterization was recorded in the two groups. (2) Record the expenses of the two groups; ? The post-catheterization care of the two groups was recorded; (4) Subjective comfort scores of the two groups after catheterization;

Countries

China

Contacts

Public ContactGuoyamin

The Second Affiliated Hospital of Guizhou University of Chinese Medicine

1961231032@qq.com+86 159 8516 2742

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026